妥洛特罗贴剂对扁桃体切除术患儿围术期呼吸不良事件的影响:随机对照试验
这项三盲随机对照试验纳入188例接受扁桃体切除术的学龄前患儿,比较术前8-10小时应用妥洛特罗贴剂(1 mg)与安慰剂对围术期呼吸不良事件的影响。
要点
- 术前8-10小时应用妥洛特罗贴剂可降低扁桃体切除术患儿围术期呼吸不良事件发生率。
- 气道梗阻和严重咳嗽的发生率在妥洛特罗组均显著低于安慰剂组。
- 需进一步研究验证妥洛特罗贴剂在更广泛小儿麻醉人群中的效果。
核心结论
- 在学龄前接受扁桃体切除术的患儿中,术前应用妥洛特罗贴剂可降低围术期呼吸不良事件的发生率。
研究设计与样本
- 三盲(患者、麻醉提供者和结局评估者)随机对照试验,共188例患者随机分配接受妥洛特罗贴剂或安慰剂。
- 妥洛特罗组接受1 mg妥洛特罗贴剂并用绷带覆盖,安慰剂组仅接受绷带覆盖,贴敷于术前8至10小时。
- 最终分析妥洛特罗组88例、安慰剂组94例。
关键数值与推荐
- 主要结局为任何围术期呼吸不良事件:氧饱和度<95%、气道梗阻、喉痉挛、支气管痉挛、严重咳嗽或喘鸣。
- 采用平均相对效应检验评估复合结局中各组分效应后取平均值。
临床怎么用
- 对于接受扁桃体切除术的学龄前患儿,可考虑术前8-10小时应用妥洛特罗贴剂以降低围术期呼吸不良事件风险。
局限性
- 研究仅纳入学龄前接受扁桃体切除术的患儿,结论外推至更广泛小儿麻醉人群需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative respiratory adverse events are common in children. We aimed to evaluate the effect of the transdermal β-2 agonist, tulobuterol, compared with that of placebo on the incidence of perioperative respiratory adverse events in pediatric patients undergoing tonsillectomy. METHODS: In this triple-blinded (patient, anesthesia provider, and outcome assessor) randomized controlled trial, 188 patients were randomly allocated to receive tulobuterol or a placebo. The tulobuterol groups received a tulobuterol patch (1 mg) masked with a bandage, whereas the placebo only received the bandage. The assigned bandage was applied to the patients 8 to 10 hours before the surgery. The primary outcome was the occurrence of any perioperative respiratory adverse events: oxygen desaturation <95%, airway obstruction, laryngospasm, bronchospasm, severe coughing, or stridor. The outcomes were evaluated using the average relative effect test, which estimates the effect of individual components of a composite outcome and then averages effects across components. RESULTS: A total of 88 and 94 patients who received tulobuterol and placebo, respectively, were analyzed. The incidence of any perioperative respiratory adverse event was lower with tulobuterol (n = 13/88; 14.7%) than that with the placebo (n = 40/94; 42.5%), with an estimated average relative risk (95% confidence interval) across components of 0.35 (0.20-0.60; P < .001). The symptoms of airway obstruction were lower with tulobuterol (n = 8/88; 9.0%) than that with the placebo (n = 32/94; 34.0%), with relative risk (95% CI) of 0.31 (0.17-0.56; P < .001). The occurrence of severe coughing was lower with tulobuterol (n = 1/88; 1.1%) than that with the placebo (n = 8/94; 8.5%), with relative risk (95% CI) of 0.15 (0.03-0.68; P = .014). CONCLUSIONS: In preschool children undergoing tonsillectomy, the preoperative application of a tulobuterol patch could decrease the occurrence of perioperative respiratory adverse events. Further studies are needed to elucidate the effect of the tulobuterol patch in a broad spectrum of pediatric anesthesia.
引用
- Kim EH, Lee SH, Kim JK, et al. Effect of Tulobuterol Patch Versus Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: A Randomized Controlled Trial. Anesth Analg. 2023. PMID: 36727868. doi:10.1213/ANE.0000000000006355
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。